Sufei Wang
Impact in
- Infectious Diseases top 5%
- COVID-19 Clinical Research Studies
- Clinical Biochemistry top 10%
Papers in
-
- COVID-19 Clinical Research Studies 8
-
- Long-Term Effects of COVID-19 6
- Co-authors
- Yang Jin (28 shared papers)Juanjuan Xu (20 shared papers)Yanling Ma (9 shared papers)Feng Wu (8 shared papers)Pei Ma (5 shared papers)Xueyun Tan (11 shared papers)Zhengrong Yin (9 shared papers)Zhilei Lv (7 shared papers)
- Journals
- Cell Death and Disease (2 papers)SAE technical papers on CD-ROM/SAE technical paper series (2 papers)EBioMedicine (2 papers)International Journal of Infectious Diseases (1 paper)Frontiers in Physiology (1 paper)
- Partner nations
- China
In The Last Decade
Sufei Wang
47 papers receiving 1.3k citations
Sufei Wang's Hit Papers
Peers
Comparison fields: 5 of 102
- Infectious Diseases 275
- Clinical Biochemistry 36
- Neurology 101
- Biotechnology 43
- Molecular Biology 383
Countries citing papers authored by Sufei Wang
This map shows the geographic impact of Sufei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sufei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sufei Wang more than expected).
Fields of papers citing papers by Sufei Wang
This network shows the impact of papers produced by Sufei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sufei Wang. The network helps show where Sufei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Sufei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 253 | |
| 2 | Intratumoural microbiota: a new frontier in cancer development and therapy Hit paper breakdown → | 2024 | 181 |
| 3 | 2021 | 102 | |
| 4 | 2020 | 60 | |
| 5 | 2022 | 51 | |
| 6 | 2022 | 49 | |
| 7 | 2021 | 43 | |
| 8 | 2019 | 41 | |
| 9 | 2021 | 37 | |
| 10 | 2020 | 36 | |
| 11 | 2021 | 36 | |
| 12 | 2021 | 34 | |
| 13 | 2019 | 30 | |
| 14 | The role of adrenergic receptors in lung cancer. | 2018 | 26 |
| 15 | 2021 | 26 | |
| 16 | 2020 | 22 | |
| 17 | 2022 | 20 | |
| 18 | 2021 | 19 | |
| 19 | 2022 | 19 | |
| 20 | 2021 | 16 |
About Sufei Wang
Sufei Wang is a scholar working on Infectious Diseases, Neurology, Fluid Flow and Transfer Processes, Pulmonary and Respiratory Medicine and Molecular Biology, having authored 48 papers that have together received 1.3k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (8 papers), Extracellular vesicles in disease (7 papers), Long-Term Effects of COVID-19 (6 papers), Lung Cancer Treatments and Mutations (5 papers), Advanced Combustion Engine Technologies (4 papers), Lung Cancer Research Studies (2 papers), Radiomics and Machine Learning in Medical Imaging (2 papers) and Cancer Immunotherapy and Biomarkers (1 paper). The work is most often cited by research in Infectious Diseases (275 citations), Clinical Biochemistry (36 citations), Neurology (101 citations), Biotechnology (43 citations) and Molecular Biology (383 citations). Sufei Wang has collaborated with scholars based in China. Frequent co-authors include Yang Jin, Juanjuan Xu, Yanling Ma, Feng Wu, Pei Ma, Xueyun Tan, Zhengrong Yin, Zhilei Lv, Limin Duan and Daquan Meng. Their work appears in journals such as Cell Death and Disease, SAE technical papers on CD-ROM/SAE technical paper series, EBioMedicine, International Journal of Infectious Diseases and Frontiers in Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.